The incidence of later-stage breast cancer has not kept pace with a substantial increase in diagnosed breast cancers, an increase achieved largely by the use of better imaging equipment and a nearly 70% screening rate among women 40 years and older. This fact, underscored in a special communication... More »
So here we go again with one more round in the battle of treatment options for localized prostate cancer. While more than 3 decades of such sparring has gotten us no closer to evidence-based conclusions, one might say that these matches do serve the purpose of bringing out the best and the worst of... More »
Prostate cancer experts agree on one issue: No single treatment can be considered universal for men diagnosed with prostate cancer. There are myriad choices and considerations to be reviewed with every diagnosis. In addition, there are conflicting data about when, or if, men require screening for... More »
Is the era of PSA screening coming to an end? Proponents say the test saves lives, but a growing number of critics contend that widespread screening does more harm than good. The ongoing controversy over the clinical value of PSA screening has long been perpetuated by a lack of persuasive data,... More »
The value of a molecular marker in cancer depends on whether its use will improve clinical outcomes. Studies on tumor biomarkers are in preliminary stages, and there is a “near total” absence of any papers examining the clinical implications of using markers, according to a speaker at the 2009... More »
RSNA presentations on prostate cancer staging and treatment, along with talks on radiation therapy for thoracic malignancies, have piqued the interest of cancer care specialists. But in general, oncologists and radiation oncologists conveyed some reservations about this year’s offerings in oncologic... More »
When the U.S. Preventive Services Task Force reported that routine prostate cancer screening for older men appears to result in little benefit, the announcement raised more than a few eyebrows in the urologic medical community. More »
It is not difficult to find resources on the topic of molecular imaging. A number of comprehensive review articles have been published1-5 and dedicated websites created (e.g., www.mi-central.org/). What follows is an introduction to this emerging... More »
This is an expertly written summary of the experience with cryotherapy as primary treatment of prostate cancer and the rationale for proceeding toward more limited, organ-sparing approaches with this procedure as focal treatment for low-risk cancers. Growing evidence of overdetection and... More »
